{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-084668","form_type":"8-K","ticker":"NNVC","cik":"0001379006","company_name":"NANOVIRICIDES, INC.","filed_at":"2026-07-17T20:45:18+00:00","discovered_at":"2026-07-17T20:46:12.344906+00:00","generated_at":"2026-07-17T20:46:23.974950+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NanoViricides enters into at-the-market sales agreement with D. Boral Capital for common stock offering","bullets":["Company entered into an At Market Issuance Sales Agreement with D. Boral Capital LLC for at-the-market sales of common stock.","Sales agent commission set at 2.0% of gross proceeds from each sale.","Shares may be sold on NYSE American or other trading markets; no minimum amount specified.","Agreement terminates upon sale of all shares or termination by either party."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-084668","json":"https://secwatch.observer/filing/0001104659-26-084668.json","markdown":"https://secwatch.observer/filing/0001104659-26-084668.md","text":"https://secwatch.observer/filing/0001104659-26-084668.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926084668/0001104659-26-084668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926084668/tm2620770d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T20:46:23.974950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}